Evista is an oral medication that has revolutionized the way women manage their health. Developed by Eli Lilly and Company, Evista is a selective estrogen receptor modulator (SERM) that helps reduce the risk of certain cancers, including breast cancer, while also providing other benefits to women's health. In this article, we will discuss the benefits of Evista and how it is revolutionizing women's health.
Evista is a SERM, which means that it works by selectively blocking the action of estrogen in certain parts of the body. In the case of Evista, it works by blocking the action of estrogen in the bones. This helps to reduce the risk of osteoporosis, a condition where bones become weak and brittle due to a loss of calcium. By blocking the action of estrogen in the bones, Evista helps to keep bones strong and healthy.
One of the most important benefits of Evista is its ability to reduce the risk of breast cancer. Studies have shown that Evista can reduce the risk of breast cancer by up to 50%. This is because Evista helps to block the action of estrogen in the breast tissue, which can help to reduce the risk of estrogen-dependent breast cancer.
As mentioned above, Evista helps to reduce the risk of osteoporosis by blocking the action of estrogen in the bones. This helps to keep bones strong and healthy, reducing the risk of fractures and other bone-related issues. In addition, Evista can also help to reduce the risk of bone loss in postmenopausal women, making it an important tool in helping women maintain their bone health.
In addition to reducing the risk of breast cancer and osteoporosis, Evista can also provide other benefits to women's health. For example, Evista can help reduce the risk of coronary heart disease, as well as reduce the risk of blood clots. It can also help to reduce the risk of stroke and can help to reduce the risk of endometrial cancer.
Evista is an important medication that is revolutionizing women's health. It helps to reduce the risk of breast cancer, osteoporosis, coronary heart disease, blood clots, stroke, and endometrial cancer. By blocking the action of estrogen in certain parts of the body, Evista helps to keep bones strong and healthy, while also reducing the risk of other health issues. For these reasons, Evista is an important tool for women's health and is revolutionizing the way women manage their health.
1.
Rising rates of head and neck cancers in England
2.
Enhanced access for patients with prostate cancer is provided by the new SPECT/CT technique, which demonstrates remarkable biomarker identification.
3.
Toxic fungus from King Tutankhamun's tomb yields cancer-fighting compounds—new study
4.
Short Shrift in Cancer Funding; Bypassing Familiar for Distant; Testing for BRCA.
5.
Cancer tumor anatomy influences the benefits of chemotherapy for patients with early-stage breast cancer.
1.
Unveiling the Invisible: The Transformative Role of Radiomics in Precision Oncology
2.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
3.
Unlocking the Mysteries of Synovial Sarcoma: A New Hope for Treatment
4.
Understanding Evans Syndrome: Causes, Symptoms, and Treatment Options
5.
Digital Oncology: How Remote Monitoring and Mobile Health Are Transforming Cancer Care
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
2.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
3.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
4.
Navigating the Complexities of Ph Negative ALL - Part I
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation